Anjum Bux, MD
Pain Medicine · Danville, KYNPI 1235162991
Payments from drug & device makers
Across 1,080 payments — averaging $551.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$279K
- Flowonix Medical Incorporated$119K
- Medtronic$99K
- Vertos Medical, Inc.$53K
- Tersera Therapeutics LLC$20K
- Foundation Fusion Solutions, LLC$10K
- plus $17K from 32 others
Across 13 payments — averaging $1025.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$13K
What the payments were for
- Consulting fees$232,52639%
- Speaking & faculty fees$294,63050%
- Travel & lodging$36,7166%
- Food & beverage$31,1955%
- Entertainment$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 455 | $278,857 |
| Flowonix Medical Incorporated | 3 | $118,654 |
| Medtronic(2 entities) | 382 | $98,981 |
| Vertos Medical, Inc. | 50 | $52,564 |
| Tersera Therapeutics LLC | 57 | $19,732 |
| Foundation Fusion Solutions, LLC | 9 | $9,878 |
| Vertiflex, Inc. | 8 | $7,560 |
| SPR Therapeutics, Inc | 10 | $1,255 |
| Curonix LLC | 18 | $1,126 |
| Spinal Simplicity, LLC | 8 | $1,125 |
| Omnia Medical, LLC | 1 | $1,000 |
| Nevro Corp. | 10 | $897 |
| Bioventus LLC | 4 | $791 |
| Stimwave Technologies Incorporated | 3 | $744 |
| Abbott | 8 | $729 |
| Painteq LLC | 2 | $368 |
| MML US, Inc. | 3 | $221 |
| Nalu Medical, Inc. | 4 | $179 |
| Stratus Medical, LLC | 2 | $131 |
| AbbVie(2 entities) | 7 | $125 |
| Averitas Pharma Inc. | 6 | $114 |
| Relievant Medsystems, Inc. | 4 | $97 |
| Kerecis Limited | 1 | $93 |
| Saluda Medical Americas, Inc. | 3 | $78 |
| Si-bone, Inc. | 2 | $65 |
| Avanos Medical | 2 | $57 |
| Acacia Pharma Inc | 4 | $53 |
| Pacira Pharmaceuticals Incorporated | 2 | $44 |
| Amgen | 2 | $31 |
| GRT US Holding, Inc. | 2 | $26 |
| Stryker | 1 | $26 |
| Vertex | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Biotronik NRO, Inc. | 1 | $18 |
| Merck | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| Pacira Therapeutics, Inc. | 1 | $14 |
| KCI USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prometra II$118,654
- SYNCHROMEDII$53,183
- mild Device Kit$51,964
- WaveWriter Alpha Prime 16$49,491
- GENERAL - THERAPIES$46,490
- GENERAL PAIN MANAGEMENT$42,083
- WAVEWRITER ALPHA$39,539
- INTELLIS ADAPTIVESTIM$26,618
- PRIALT$19,146
- SPECTRA WAVEWRITER$14,222
- VANTA ADAPTIVESTIM$9,444
- Superion ISS$7,504
- Superion Indirect Decompression System$4,556
- ASCENDA$2,500
- PRECISION$2,000
- HA MINUTEMAN G3-R$908
- SPRINT PNS System$903
- StimQ Receiver Stimulator Kit Channel A US w Receiver$714
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$714
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$714
How this compares
$595,717 in reported general payments places this provider in the 95th percentile of 90 pain medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 19 | $68,861 |
| Xtampza ErOxycodone Myristate | 12 | $15,314 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 642 | $15,012 |
| LinzessLinaclotide | 26 | $13,318 |
| Oxycodone Hcl | 437 | $11,242 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 626 | $10,298 |
| Gabapentin | 943 | $9,722 |
| Fentanyl | 105 | $8,125 |
| Pregabalin | 368 | $7,426 |
| AmantadineAmantadine Hcl | 50 | $6,487 |
| Ondansetron Hcl | 36 | $4,495 |
| Tizanidine Hcl | 157 | $3,703 |
| Meloxicam | 62 | $3,544 |
| Lidocaine | 24 | $2,240 |
| Tramadol Hcl | 277 | $1,660 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GRT US Holding, Inc.Qutenza | $26 | $68,86119 claims |
| AbbVieLinzess | $125 | $13,31826 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 90 pain medicine providers in Kentucky.
Other pain medicine in Danville
- Christopher MallardLexington$84K
- Timothy BeachamLouisville$53K
- Michael HarnedLexington$45K
- Vinod MuniswamyGeorgetown$39K
- John RuxerPaducah$33K
- Mazhar RasulLexington$30K
- Tejas ShahAshland$23K
- Lance HoffmanFlorence$22K
- Jonathan GraingerFlorence$22K
- Lasha EsebuaHenderson$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.